Evidence map›Paper›PMID 17699568›Full record

ArticleJournal of virology2007

Viral sequence evolution in acute hepatitis C virus infection.

Thomas Kuntzen, Joerg Timm, Andrew Berical, Lia L Lewis-Ximenez, Andrea Jones, Brian Nolan, Julian Schulze zur Wiesch, Bin Li, Arne Schneidewind, Arthur Y Kim and 3 more

Abstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Epigenetic scars of CD8Nature immunology · 2021
    Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Differentiation of exhausted CD8Nature immunology · 2021
    Article
  8. Biased Mutation and Selection in RNA Viruses.Molecular biology and evolution · 2021
    Article
  9. Review
  10. Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Thomas KuntzenMassachusetts General Hospital, Infectious Disease, 13th Street, Charlestown, MA 02129, USA.
Joerg Timm
Andrew Berical
Lia L Lewis-Ximenez
Andrea Jones
Brian Nolan
Julian Schulze zur Wiesch
Bin Li
Arne Schneidewind
Arthur Y Kim
Raymond T Chung
Georg M Lauer
Todd M Allen

Funding

The role of NK cells during acute HCV infection and antiviral therapyU19AI066345 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LAUER, GEORG MICHAEL · 2005 to 2014
$8.5M
CD8 T Cell Selective Pressure and HCV Sequence EvolutionR01AI067926 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2006 to 2009
$711k
NIAID NIH HHS R01 AI067926NIAID NIH HHS R01 AI 067926-01NIAID NIH HHS U19 AI066345NIAID NIH HHS U19 AI 066345-02
6 · The paper itself

Abstract

CD8(+)-T-cell responses play an important role in the containment and clearance of hepatitis C virus (HCV) infection, and an association between viral persistence and development of viral escape mutations has been postulated. While escape from CD8+ -T-cell responses has been identified as a major driving force for the evolution of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV), a broader characterization of this relationship is needed in HCV infection. To determine the extent, kinetics, and driving forces of HCV sequence evolution, we sequenced the entire HCV genome longitudinally in four subjects monitored for up to 30 months after acute infection. For two subjects the transmission sources were also available. Of 53 total non-envelope amino acid substitutions detected, a majority represented forward mutations away from the consensus sequence. In contrast to studies in HIV and SIV, however, only 11% of these were associated with detectable CD8+ T-cell responses. Interestingly, 19% of non-envelope mutations represented changes toward the consensus sequence, suggesting reversion in the absence of immune pressure upon transmission. Notably, the rate of evolution of forward and reverse mutations correlated with the conservation of each residue, which is indicative of structural constraints influencing the kinetics of viral evolution. Finally, the rate of sequence evolution was observed to decline over the course of infection, possibly reflective of diminishing selection pressure by dysfunctional CD8+ T cells. Taken together, these data provide insight into the extent to which HCV is capable of evading early CD8+ T-cell responses and support the hypothesis that dysfunction of CD8+ T cells may be associated with failure to resolve HCV infections.

Indexed as

Amino AcidsCD8-Positive T-LymphocytesEpitopes, T-LymphocyteEvolution, MolecularGenome, ViralHepacivirusHepatitis CHLA AntigensHumansInterferon-gammaLeukocytes, MononuclearMolecular Sequence DataMutationPhylogenyT-LymphocytesAmino AcidsEpitopes, T-LymphocyteHLA AntigensInterferon-gamma

Identifiers

PMID17699568
PMCPMC2168804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.